Xadago 100 mg/1 (Safinamide Mesylate TABLET, FILM COATED) 100 mg/1

Xadago 100 mg tablets contain safinamide mesylate, a medication used to manage symptoms of Parkinson's disease. This film-coated tablet is designed for oral use and is manufactured by MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.

Strength

100 mg/1

Pack Size

1 BLISTER PACK in 1 CARTON (27505-111-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Manufacturer / TM Owner

MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Xadago is primarily used as an add-on treatment for Parkinson's disease in patients who are already taking levodopa and carbidopa. Safinamide mesylate works by modulating dopamine levels in the brain, which can help alleviate symptoms such as tremors, stiffness, and difficulty moving. It is often prescribed to improve motor function and reduce fluctuations in symptoms.

Side Effects

Common effects of Xadago may include dizziness, nausea, and insomnia. Some users might experience hallucinations or uncontrolled movements. It is important to monitor for any unusual changes in behavior or physical symptoms while taking this medication.

Precautions & Warnings

Xadago should be used with caution in patients with a history of mental health issues, as it may increase the risk of hallucinations or other psychiatric symptoms. It is also important to avoid sudden discontinuation of the medication without consulting a healthcare provider. Patients with liver or kidney problems should discuss their condition with a healthcare professional before starting Xadago.

Avoid Interactions

Xadago may interact with other medications that affect dopamine levels, such as other Parkinson's disease treatments. It is also important to be cautious when taking Xadago with medications that are metabolized by the liver, as safinamide mesylate can affect liver enzymes. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Xadago is used as an add-on treatment for Parkinson's disease to help manage symptoms like tremors and stiffness.

Xadago is taken orally, typically once daily, with or without food. Follow the dosage instructions provided by your healthcare provider.

Common side effects may include dizziness, nausea, insomnia, and hallucinations. Always consult a healthcare provider for personalized advice.

Xadago may interact with other medications, especially those that affect dopamine levels or are metabolized by the liver. Always inform your healthcare provider about all medications you are taking.

Patients with a history of mental health issues or liver/kidney problems should use Xadago with caution and consult a healthcare provider before starting the medication.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.